Organigram (OGI) announced that James Yamanaka, formerly global head of strategy for British American Tobacco (BTI), has been appointed the company’s new CEO. Yamanaka is expected to assume the role effective on or about January 15, 2026. Yamanaka will also join the company’s board of directors when he assumes the role of CEO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGI: